From Our Readers

From Our Readers

The Subspecialist Will Televisit You Now

Prior to the COVID-19 pandemic, health-care providers, payers, and patients had all gradually warmed up to the opportunities for telemedicine afforded by high-speed internet...
You Make the Call

Reader’s Response: Is warfarin recommended for a patient with recurrent coronary artery closure?

Here’s how readers responded to a You Make the Call question about management of a patient with recurrent coronary artery closure. Disclaimer: ASH does not recommend...
You Make the Call

Reader’s Responses: Should this patient with DLBCL receive rituximab maintenance after R-CHOP?

Here’s how readers responded to a You Make the Call question about rituximab maintenance after R-CHOP for a patient with stage 4B diffuse large...
You Make the Call

Reader Responses: How would you treat these patients with acute stroke who are positive...

Here’s how readers responded to a You Make the Call question about anticoagulation for patients with antiphospholipid antibodies and a history of stroke. Disclaimer: ASH...
You Make the Call

Reader Responses: Would rituximab re-treatment help this patient with hemolytic anemia?

Here’s how readers responded to a You Make the Call question about treatment of Coombs-positive hemolytic anemia in a patient who declines to undergo...

The Costs of Pursuing Cancer Cures

In this edition, Jori May, MD, reviews The First Cell: And the Human Costs of Pursuing Cancer to the Last, in which hematologist-oncologist Azra...

COVID-19, Cancer, and the Need for Clarity

By Aakash Desai, MD, MPH; Gilberto Lopes Jr., MD, MBA; Nicole M. Kuderer, MD; Brian I. Rini, MD; Gary H. Lyman, MD, MPH, FRCP;...
You Make the Call

Reader Responses: How would you treat a frail patient with relapsed hairy cell leukemia variant?

Here’s how readers responded to a You Make the Call question about treatment of early-relapsing hairy cell leukemia variant. Disclaimer: ASH does not recommend or...

Leukemia’s Collision With Souls and Soulcraft

In this edition, Jason Gotlib, MD, MS, reviews When Blood Breaks Down: Life Lessons from Leukemia by Mikkael Sekeres, MD, MS, which explores how...
You Make the Call

Reader Responses: What is the best consolidation therapy for this patient with primary central...

Here’s how readers responded to a You Make the Call question about the treatment of primary central nervous system lymphoma. Disclaimer: ASH does not recommend...
Advertisement

Current Issue

August 2020 Volume 6, Issue 10

This issue looks at the rapid expansion of telemedicine, explores access to leukemia treatment in Brazil, and more.